- Home
- EQR vs DXCM Comparison
EQR vs DXCM Comparison
Compare EQR & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQR | DXCM |
|---|---|---|
| Founded | 1993 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5B | 25.9B |
| IPO Year | 1993 | 2005 |
Fundamental Metrics
Financial Performance| Metric | EQR | DXCM |
|---|---|---|
| Price | $61.55 | $66.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 21 |
| Target Price | $70.00 | ★ $86.86 |
| AVG Volume (30 Days) | 2.1M | ★ 5.1M |
| Earning Date | 02-02-2026 | 10-30-2025 |
| Dividend Yield | ★ 4.46% | N/A |
| EPS Growth | ★ 24.49 | 7.75 |
| EPS | ★ 3.03 | 1.80 |
| Revenue | $3,078,827,000.00 | ★ $4,515,900,000.00 |
| Revenue This Year | $5.06 | $17.41 |
| Revenue Next Year | $3.55 | $12.78 |
| P/E Ratio | ★ $20.47 | $36.68 |
| Revenue Growth | 4.69 | ★ 14.21 |
| 52 Week Low | $58.38 | $54.11 |
| 52 Week High | $75.86 | $93.25 |
Technical Indicators
Market Signals| Indicator | EQR | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 55.55 | 55.99 |
| Support Level | $60.47 | $65.56 |
| Resistance Level | $62.64 | $68.19 |
| Average True Range (ATR) | 0.94 | 1.85 |
| MACD | 0.13 | 0.11 |
| Stochastic Oscillator | 65.44 | 37.61 |
Price Performance
Historical ComparisonAbout EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.